RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Association between the Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism and Alexithymia in Patients with Obsessive-Compulsive Disorder

      한글로보기

      https://www.riss.kr/link?id=A103610779

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Alexithymia, defined as a deficit in the ability to recognize and describe one’s own feelings, may be related to the developmentand maintenance of obsessive-compulsive symptoms. The aim of this study was to evaluate the association between ...

      Purpose: Alexithymia, defined as a deficit in the ability to recognize and describe one’s own feelings, may be related to the developmentand maintenance of obsessive-compulsive symptoms. The aim of this study was to evaluate the association between the catechol-O-methyltransferase (COMT) Val158Met polymorphism and alexithymia in patients with obsessive-compulsive disorder (OCD).
      Materials and Methods: We recruited 244 patients with OCD (169 males, 75 females). Alexithymia was assessed using the 20-item Toronto Alexithymia Scale (TAS-20), and genotyping of the COMT Val158Met polymorphism was evaluated.
      Results: Patients with the COMT Val/Val genotype had significantly higher total and “difficulty identifying feelings” (DIF) subdimensionscores than those with the Val/Met or Met/Met genotypes. Patients with the COMT Val/Val genotype had significantly higher “difficulty describing feelings” (DDF) subdimension scores than those with the COMT Val/Met genotype. However, there were no differences in the scores for the “externally oriented thinking” (EOT) subdimension among the three genotypes.
      Conclusion: These results indicate that the high-activity Val allele of the COMT Val158Met polymorphism is associated with increasedalexithymic traits in patients with OCD. The present finding suggests that alexithymia is an endophenotype of OCD that is mediated by the COMT Val158Met polymorphism.

      더보기

      참고문헌 (Reference)

      1 Büttner-Westphal H, "Yale-Brown Obsessive Compulsive Scale (authorized German translation)" 1 : 226-233, 1991

      2 Bagby RM, "The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure" 38 : 23-32, 1994

      3 Goerlich KS, "The sound of feelings: electrophysiological responses to emotional speech in alexithymia" 7 : e36951-, 2012

      4 Dere J, "The cultural shaping of alexithymia: values and externally oriented thinking in a Chinese clinical sample" 54 : 362-368, 2013

      5 Kooiman CG, "The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20" 53 : 1083-1090, 2002

      6 Kano M, "The alexithymic brain: the neural pathways linking alexithymia to physical disorders" 7 : 1-, 2013

      7 Bagby RM, "The Twenty-item Toronto Alexithymia Scale--II. Convergent, discriminant, and concurrent validity" 38 : 33-40, 1994

      8 First MB, "Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)" American Psychiatric Press 1996

      9 Kano M, "Serotonin transporter gene promoter polymorphism and alexithymia" 65 : 76-82, 2012

      10 Taylor GJ, "Recent developments in alexithymia theory and research" 45 : 134-142, 2000

      1 Büttner-Westphal H, "Yale-Brown Obsessive Compulsive Scale (authorized German translation)" 1 : 226-233, 1991

      2 Bagby RM, "The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure" 38 : 23-32, 1994

      3 Goerlich KS, "The sound of feelings: electrophysiological responses to emotional speech in alexithymia" 7 : e36951-, 2012

      4 Dere J, "The cultural shaping of alexithymia: values and externally oriented thinking in a Chinese clinical sample" 54 : 362-368, 2013

      5 Kooiman CG, "The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20" 53 : 1083-1090, 2002

      6 Kano M, "The alexithymic brain: the neural pathways linking alexithymia to physical disorders" 7 : 1-, 2013

      7 Bagby RM, "The Twenty-item Toronto Alexithymia Scale--II. Convergent, discriminant, and concurrent validity" 38 : 33-40, 1994

      8 First MB, "Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)" American Psychiatric Press 1996

      9 Kano M, "Serotonin transporter gene promoter polymorphism and alexithymia" 65 : 76-82, 2012

      10 Taylor GJ, "Recent developments in alexithymia theory and research" 45 : 134-142, 2000

      11 Hermes S, "No association between catechol-O-methyltransferase val158met polymorphism and alexithymia" 57 : 51-61, 2011

      12 Koh MJ, "Lack of Association between Oxytocin Receptor (OXTR) Gene Polymorphisms and Alexithymia: Evidence from Patients with Obsessive-Compulsive Disorder" 10 : e0143168-, 2015

      13 Walter NT, "Interaction effect of functional variants of the BDNF and DRD2/ANKK1 gene is associated with alexithymia in healthy human subjects" 73 : 23-28, 2011

      14 De Berardis D, "Insight and alexithymia in adult outpatients with obsessivecompulsive disorder" 255 : 350-358, 2005

      15 Opmeer EM, "Influence of COMT val158met genotype on the depressed brain during emotional processing and working memory" 8 : 73290-, 2013

      16 Lachman HM, "Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders" 6 : 243-250, 1996

      17 Bevilacqua L, "Genetics of emotion" 15 : 401-408, 2011

      18 Picardi A, "Genetic influences on alexithymia and their relationship with depressive symptoms" 71 : 256-263, 2011

      19 Jørgensen MM, "Genetic and environmental factors in alexithymia: a population-based study of 8,785 Danish twin pairs" 76 : 369-375, 2007

      20 Loas G, "Factor analysis of the French version of the 20-Item Toronto Alexithymia Scale (TAS-20)" 29 : 139-144, 1996

      21 Witte AV, "Effects of COMT polymorphisms on brain function and behavior in health and disease" 88 : 418-428, 2012

      22 Nieoullon A, "Dopamine: a key regulator to adapt action, emotion, motivation and cognition" 16 (16): S3-S9, 2003

      23 Lee Y, "Development and validation of a Korean version of the 20-item Toronto Alexithymia Scale (TAS-20K)" 35 : 888-899, 1996

      24 Larsen JK, "Cognitive and emotional characteristics of alexithymia: a review of neurobiological studies" 54 : 533-541, 2003

      25 Matsumoto M, "Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function" 116 : 127-137, 2003

      26 Aleman A, "Brain imaging, genetics and emotion" 79 : 58-69, 2008

      27 Ham BJ, "Association between the catechol O-methyltransferase Val108/158Met polymorphism and alexithymia" 52 : 151-154, 2005

      28 Jongen S, "An investigation of facial emotion recognition impairments in alexithymia and its neural correlates" 271 : 129-139, 2014

      29 Kim SJ, "An association study of catechol-O-methyltransferase and monoamine oxidase A polymorphisms and personality traits in Koreans" 401 : 154-158, 2006

      30 De Berardis D, "Alexithymia, suicidal ideation, and serum lipid levels among drug-naïve outpatients with obsessive-compulsive disorder" 36 : 125-130, 2014

      31 Bailey PE, "Alexithymia, somatization and negative affect in a community sample" 150 : 13-20, 2007

      32 Assogna F, "Alexithymia is a non-motor symptom of Parkinson disease" 20 : 133-141, 2012

      33 Roh D, "Alexithymia in obsessive-compulsive disorder: clinical correlates and symptom dimensions" 199 : 690-695, 2011

      34 Grabe HJ, "Alexithymia in obsessive-compulsive disorder - results from a family study" 75 : 312-318, 2006

      35 Moriguchi Y, "Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)" 1 : 7-, 2007

      36 Kang JI, "Abnormalities of emotional awareness and perception in patients with obsessivecompulsive disorder" 141 : 286-293, 2012

      37 Montgomery SA, "A new depression scale designed to be sensitive to change" 134 : 382-389, 1979

      38 Henry JD, "A new conceptualization of alexithymia in the general adult population: implications for research involving older adults" 60 : 535-543, 2006

      39 Baughman HM, "A behavior genetic analysis of trait emotional intelligence and alexithymia: a replication" 16 : 554-559, 2013

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼